Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep886 | Growth hormone IGF axis - basic | ECE2017

Nodular thyroid disease in acromegaly: cohort of 69 patients at a single institution

Alvarez-Escola Cristina , Gonzalez Diego Meneses , Dominguez Oscar Moreno , de la Morena Lucrecia Herranz

Materials and methods: The aims were to evaluate the frequency of nodular thyroid disease (NTD) in acromegalic patients and to correlate clinical and metabolic features with disease activity and other. We conducted a cross-sectional study including retrospectively 69 acromegalic patients attending to an University Hospital in Madrid, Spain between 1980 and 2016. Mean age was 63 (32–92) years, 63.8% of patients were female. Mean age at diagnosis of acromegaly was 48 (11&#1...

ea0092ps2-15-09 | Hyperthyroidism | ETA2023

Long-term follow-up after antithyroid drug treatment withdrawal in patients with the first episode of graves` disease: a retrospective cohort study in spain

Meneses Diego , Sanchez Lechuga Begona , Velez Romero Maria , Sierra Poyatos Roberto , Vazquez Martinez Clotilde , Cardenas Salas Jersy

Background: Despite a high relapse rate, antithyroid drugs (ATDs) remain the first-line therapy of Graves’ disease (GD). Long-term follow-up studies of GD in Spain are scarce. Our aims were to identify clinical differences between patients who relapsed vs those who attained remission and to describe the relapse rate of GD after ATD withdrawal.Methods: We analyzed patients with the first episode of GD who were treated with ATDs during 2010 - 2020, in...

ea0070aep342 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Modification of standard thresholds improves performance of noninvasive scores of liver fibrosis in patients undergoing bariatric surgery

Meneses Diego , Cos Blanco Ana , Corripio Ramón , Méndez Carmen , Olveira Martín Antonio , Romero Míriam , Vicent David , Herranz Lucrecia

Background: In bariatric surgery (BS) patients, nonalcoholic fatty liver disease and fibrosis are present in up to 90% and 24%, respectively. Several fibrosis risk scores have been developed and have been validated in cohorts different from morbid obesity (MO). We aimed to determine whether established liver fibrosis scores were accurate in predicting fibrosis in MO subjects.Material and Methods: Cross-sectional analysis in a cohort of MO patients underg...

ea0073aep809 | Late Breaking | ECE2021

Comparison of the clinical efficacy of Semaglutide between DPP4-inhibitor-naive and DPP4-inhibitor-experienced patients in a real world setting in Spain

Roberto Miguel Sierra Poyatos , Jersy Jair Cardenas Salas , Luiza Luca Bogdana , Nancy María Sanchez Gomez , Naiara Modroño Mostoles , Begoña Sánchez Lechuga , Cruces Vega Eva , Maria Jesus Silva Rodriguez , María De La Paz Gómez Montes , Diego Meneses González , Montoya Alvarez Teresa , María de los Angeles Velez Romero , Estrella Santos Alicia , Ortega Juaristi Maite , Maria De Los Angeles Gonzalo Redondo , Vazquez Martinez Clotilde

IntroductionGlucose and weight control effectiveness in patients with Type 2 diabetes (T2D) in treatment with DPP4 inhibitors (DPP4i) that switch to semaglutide is scarce. We aim to assess it in a real-world setting of DPP4i-experienced patients and compare it to DPP4i-naive patients.MethodsPatients with T2D that were prescribed Once-Weekly semaglutide in 4 hospitals in Madrid-Spain were identified. Patients ...